Your browser doesn't support javascript.
loading
Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection.
Nicol, Melanie R; Joshi, Abhay; Rizk, Matthew L; Sabato, Philip E; Savic, Radojka M; Wesche, David; Zheng, Jenny H; Cook, Jack.
Afiliación
  • Nicol MR; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Joshi A; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Rizk ML; Quantitative Pharmacology and Pharmacometrics, Merck & Co Inc, Kenilworth, New Jersey, USA.
  • Sabato PE; Quantitative Pharmacology and Pharmacometrics, Merck & Co Inc, Kenilworth, New Jersey, USA.
  • Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
  • Wesche D; Certara, Princeton, New Jersey, USA.
  • Zheng JH; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Cook J; Clinical Pharmacology Department, Global Product Development, Pfizer Inc, Groton, Connecticut, USA.
Clin Pharmacol Ther ; 108(6): 1135-1149, 2020 12.
Article en En | MEDLINE | ID: mdl-32687630

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Cloroquina / Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Cloroquina / Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos